New NIH-Funded Johns Hopkins Medicine Study Finds Switching to Integrase Inhibitors ...
|
Antiretroviral therapies that treat HIV by blocking
specific enzymes the virus uses to multiply can cause metabolic
complications, including weight ... |
One2PrEP Takes HIV Prevention to Center Stage, Using Culture and Conversation to Break Stigma
Gilead has now developed an awareness campaign, One2PrEP, aimed at having public conversations about HIV prevention and that they belong in the ... View article...